TAC1 and ischemia reperfusion injury: The administration of different doses of substance P antagonist, aprepitant (5 mg, 10 mg, 20 mg/kg), in rats 30 minutes before subjecting them to ischemia-reperfusion injury resulted in significant protection, and heart injury was significantly reduced in a dose-dependent manner.